Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

Phase 2 trial of BMF-219 by Biomea Fusion studies insulin sensitivity and beta cell regeneration in Type 1 Diabetes, aiming to transform treatment.
Learn how automated insulin delivery, including new data on the MiniMed 780G system, improves glycemic control and quality of life for pregnant women with type 1...
Explore the emerging effects of GLP-1 receptor agonists on glycemic control and weight management, including their potential impact on birth control pill absorption and...
Most people with diabetes know when they are low, but others have difficulty detecting it or are completely unaware. This is known as hypoglycemia unawareness.
Discover the latest in gestational diabetes management, including CGM technology, screening debates, and possible new treatments like inhaled insulin.
The daily pill Rezdiffra is the first treatment for people with a type of liver disease known as MASH, which affects up to 20% of people with type 2 diabetes.
The FDA has approved Wegovy (semaglutide) for reduction of major adverse cardiovascular events (MACE) in people with obesity and overweight and without diabetes, based...
For adults with type 1 diabetes, the adoption of automated insulin delivery systems can be life-changing. Emerging research shows the same benefits extend to children...
In new studies presented at ATTD, CGM used with GLP-1s led to greater A1C reductions than GLP-1s alone.
Novo Nordisk’s FLOW trial was stopped early after results showed that Ozempic (semaglutide) slows progression of kidney disease in people with type 2 diabetes and CKD.
Universal screening for type 1 diabetes is closer than ever. Coming soon is an international guidance document developed by JDRF and diabetes experts worldwide to...
While AID has traditionally been used in type 1 diabetes, new data suggests this technology has many of the same benefits in type 2 – namely, improving time in range and...
New study explores the impact of stress and environment on adults with diabetes through a brief online survey.
Exploring metformin as a treatment for gestational diabetes: This article delves into the efficacy, safety, and patient satisfaction of metformin compared to insulin,...
Low vision or blindness is most often a result of eye disease. People living with vision loss and diabetes share advice on the importance of eye screenings and the best...
A recent study supports the idea that metformin may have a role in dementia prevention. Studies are ongoing to provide a definitive answer.
UVA’s PEDAP-AI trial now recruiting for AI-assisted insulin pump settings in kids with type 1 diabetes ages 2-5 using Tandem pump and Dexcom CGM systems.
A new analysis has identified biomarkers that significantly improve predicting cardiovascular risk in people with type 2 diabetes. Could these biomarkers change how...
The new Look AHEAD trial analysis shows major heart and kidney benefits for type 2 diabetes patients in remission, reshaping views on lifestyle changes.
Explore the crucial link between diabetes and accelerated age-related muscle loss (sarcopenia), its impact on health, and strategies for managing muscle health in people...

Pages